Does Patient Centred Care improve medication Adherence?
Research type
Research Study
Full title
influence of Patient Centred Care (PCC) on adherence to oral hypoglycaemic drugs in patients with type 2 Diabetes Mellitus in the Borough of Hounslow ( UK).
IRAS ID
194808
Contact name
Thewodros Leka
Contact email
Sponsor organisation
Middlesex University
Duration of Study in the UK
0 years, 10 months, days
Research summary
Patient –centred Care ( PCC) is defined as ’holistic, empowering care that tailors support according to the individual’s priorities and needs’.
‘Patient – centred Pharmaceutical care’( PCPC) is enabling patients to make the best use of their medicines by involving them in decision about their own care. Patient Centred care (PCC) is a wider concept which encompasses Patient Centred Pharmaceutical Care (PCPC).
The aim of the study is to evaluate the implementation and impact of Patient Centred Care (PCC) with particular emphasis on pharmaceutical care in improving medicine adherence and clinical out-comes of patients with type 2 Diabetes in the Borough of Hounslow (UK).
Type 2 diabetes mellitus is one of the chronic diseases with immense health care cost and high disease burden globally. There is an urgent need to develop methods to improve diabetes care in a society. In UK, in the last few years, diabetes care and management policies and guidelines have been reviewed number of times in an attempt to achieve improved health out-comes. The National Institute for Health and Excellence (NICE 2009) recommended ‘Patient-centred Care’ to every person living with type 2 Diabetes.
Studies have showed that diabetes care based on the principles of patient centred care can enhance blood sugar level control and clinical-out comes, in particular when patients engage actively in their self-management.
However, there is lack of empirical data in UK measuring the impact of patient centred care with particular emphasis on pharmaceutical care in improving clinical outcomes and medication adherence.
The borough of Hounslow has high prevalence of type 2 diabetes, deprivation and significant percentage of ethnic groups with high risk factors for diabetes which makes the borough a good candidate to assess the management of type 2 diabetes and implementation of PCC.REC name
London - Riverside Research Ethics Committee
REC reference
17/LO/1992
Date of REC Opinion
11 Dec 2017
REC opinion
Unfavourable Opinion